Taro Pharmaceutical Industries Ltd. Company Profile

18:57 EDT 22nd June 2018 | BioPortfolio

News Articles [1003 Associated News Articles listed on BioPortfolio]

Taro to Announce Third Quarter Results on February 7, 2018

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2017, after the ...

Kal Sundaram appointed as chairman of Taro Pharmaceutical

Taro Pharmaceutical Industries Ltd. (Taro) announced that Dilip Shanghvi has resigned, effective April 18, as chairman and a member of Taro's board of directors in order to focus on other growth prior...

Taro Annual Report on Form 20-F Available

For Fiscal Year Ended March 31, 2018 Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March ...

Taro to Announce Full Year Results on May 17, 2018

Earnings Call to Discuss Results to be Conducted Friday, May 18 at 8:00 am EDT Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release ...

Taro Pharmaceutical's (TARO) CEO Uday Baldota on Q4 2018 Results - Earnings Call Transcript

Taro Pharmaceutical Industries Ltd TARO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19022018] Prices from USD $250

SummaryTaro Pharmaceutical Industries Ltd Taro, a subsidiary of Sun Pharmaceutical Industries Ltd, research develops and markets healthcare products. The company manufactures prescription drugs, nonpr...

Comparing Teva Pharmaceutical Industries

Amgen and Teva Pharmaceutical Industries are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional owne...

Weekly Analysts' Ratings Changes for Teva Pharmaceutical Industries

A number of firms have modified their ratings and price targets on shares of Teva Pharmaceutical Industries recently: 1/22/2018 - Teva Pharmaceutical Industries was given a new $20.00 price target on ...

Drugs and Medications [739 Associated Drugs and Medications listed on BioPortfolio]

Cetirizine hydrochloride [Taro Pharmaceutical Industries, Ltd.]

Children's Cetirizine Hydrochloride Oral Solution

Lithium carbonate [Sun Pharmaceutical Industries Limited ]

Lithium Carbonate Tablets USP

Epinastine hydrochloride [Sun Pharmaceutical Industries Limited ]

Epinastine Hydrochloride Ophthalmic Solution 0.05%Sterile

Cetirizine hydrochloride [Taro Pharmaceutical Industries, Ltd.]

Cetirizine Hydrochloride Oral Solution

Dawnmist hypoallergenic petroleum [Donovan Industries, Inc.]

DawnMist Hypoallergenic Petroleum Jelly

PubMed Articles [600 Associated PubMed Articles listed on BioPortfolio]

Literary evidence for taro in the ancient Mediterranean: A chronology of names and uses in a multilingual world.

Taro, Colocasia esculenta (L.) Schott, is a vegetable and starchy root crop cultivated in Asia, Oceania, the Americas, Africa, and the Mediterranean. Very little is known about its early history in th...

Adsorption of Cu (II) and Ni (II) from aqueous solutions by taro stalks chemically modified with diethylenetriamine.

Taro stalks (TS) were modified by diethylenetriamine (DETA) to obtain the modified taro stalks adsorbents (recorded as MTSA). This kind of raw material is unprecedented and the method of modification ...

Prioritizing Type of Industry through Health Risk Assessment of Occupational Exposure to Dimethylformamide in the Workplace.

The purpose of this study was to classify hazards at an industrial level and evaluate the exposure risks of workers exposed to dimethylformamide (DMF) used as a solvent in the workplace and to determi...

Genome sequence resource for the oomycete taro pathogen Phytophthora colocasiae.

Phytophthora colocasiae is a phytopathogenic oomycete that causes leaf blight and corm rot on taro (Colocasia esculenta), an important staple crop in the tropics. The impact of P. colocasiae is a seri...

A network analysis of indirect carbon emission flows among different industries in China.

Indirect carbon emissions account for a large ratio of the total carbon emissions in processes to make the final products, and this implies indirect carbon emission flow across industries. Understandi...

Clinical Trials [326 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

The objective of this study is to evaluate the comparative bioavailability between tamsulosin hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.; distribute...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

A Therapeutic Equivalence Study of Two Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

The primary objectives are to establish the therapeutic equivalence of imiquimod cream 5%, manufactured by Taro Pharmaceuticals Inc. and Aldara (imiquimod) cream, manufactured by 3M, and t...

Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis

To demonstrate comparable safety and efficacy of Taro Pharmaceuticals Inc. butenafine hydrochloride cream 1% (test product) and Lotrimin Ultra® cream (reference listed drug) in the treatm...

Companies [2189 Associated Companies listed on BioPortfolio]

 Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries develops, manufactures, and markets high-quality generic and branded pharmaceuticals, both prescription and over-the-counter, used by patients in countries around the wo...

Taro Pharmaceutical Ind.

Taro markets a broad range of prescription and over-the-counter products in the United States. We are a leading manufacturer and supplier of topical dermatological products and also have a growing li...

Taro Pharmaceuticals U.S.A., Inc.

Taro entered the U.S. market in 1988, after establishing its Canadian subsidiary in 1984 and receiving approval of its first topical product in the United States.The U.S. has become Taro’s largest m...

Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integr...

More Information about " Taro Pharmaceutical Industries Ltd." on BioPortfolio

We have published hundreds of  Taro Pharmaceutical Industries Ltd. news stories on BioPortfolio along with dozens of  Taro Pharmaceutical Industries Ltd. Clinical Trials and PubMed Articles about  Taro Pharmaceutical Industries Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of  Taro Pharmaceutical Industries Ltd. Companies in our database. You can also find out about relevant  Taro Pharmaceutical Industries Ltd. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record